Intellia Therapeutics, Inc. (NTLA) vs uniQure N.V. (QURE)
- Intellia Therapeutics, Inc. NTLA 11.42 +0.71%
- uniQure N.V. QURE 21.72 −3.55%
Intellia Therapeutics, Inc. and uniQure N.V. are both Biotechnology companies. Intellia Therapeutics, Inc. and uniQure N.V. are of similar size ($1.6B and $1.6B). uniQure N.V. grew revenue faster over the last twelve months: 30.2% against 12.6%. Intellia Therapeutics, Inc. has the higher net margin (−672.2% vs −1,350.7%) and the lower return on invested capital (−91.3% vs 0.00%). Across the 18 metrics below, Intellia Therapeutics, Inc. leads on 11 and uniQure N.V. on 7.
Valuation
Profitability
| Metric | NTLA | QURE | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 92.49% | 65.16% |
| Operating margin | (711.66%) | (1,071.53%) | 0.00% |
| Net margin | (672.16%) | (1,350.73%) | 0.00% |
| Free cash flow margin | (585.82%) | (864.67%) | 0.00% |
| Return on equity | (55.44%) | (157.61%) | (56.36%) |
| Return on assets | (45.55%) | (32.13%) | (48.04%) |
| Return on invested capital | (91.28%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack